Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-11 5:23 pm Sale | 13D | EIGER BIOPHARMACEUTICALS INC C EIGR | Vivo Ventures VI LLC | 4,166 13% | -1,662,925 (-99.75%) | View |
| 2022-02-02 7:11 pm Purchase | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | BlackRock Inc. BLK | 2,472,964 7.3% | 97,678 (+4.11%) | View |
| 2022-01-21 3:25 pm Purchase | 13D | EIGER BIOPHARMACEUTICALS INC C EIGR | AMERIPRISE FINANCIAL INC AMP | 7,048,834 20.75% | 1,189,173 (+20.29%) | View |
| 2021-09-10 10:31 am Purchase | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | AMERIPRISE FINANCIAL INC AMP | 5,859,661 17.26% | 1,937,826 (+49.41%) | View |
| 2021-08-06 4:30 pm Sale | 13D | EIGER BIOPHARMACEUTICALS INC C EIGR | Vivo Ventures VI LLC | 1,667,091 4.91% | -120,000 (-6.71%) | View |
| 2021-02-16 3:18 pm Purchase | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | 683 Capital Management LLC | 2,683,600 8.2% | 833,600 (+45.06%) | View |
| 2021-02-12 4:30 pm Unchanged | 13D | EIGER BIOPHARMACEUTICALS INC C EIGR | Vivo Ventures VI LLC | 1,787,091 5.5% | 0 (Unchanged) | View |
| 2021-02-11 08:25 am Sale | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0% | -2,225,000 (Position Closed) | View |
| 2021-01-29 09:56 am Purchase | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | BlackRock Inc. BLK | 2,375,286 7.3% | 485,594 (+25.70%) | View |
| 2021-01-11 11:46 am Purchase | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | AMERIPRISE FINANCIAL INC AMP | 3,921,835 12.06% | 3,921,835 (New Position) | View |
| 2021-01-04 11:29 am Sale | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | Broadfin Capital LLC | 0 0% | -1,236,368 (Position Closed) | View |
| 2020-02-14 4:34 pm Sale | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | RA CAPITAL MANAGEMENT L.P. | 0 0% | -2,415,458 (Position Closed) | View |
| 2020-02-14 2:29 pm Sale | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | EcoR1 Capital LLC | 449,338 1.8% | -1,146,305 (-71.84%) | View |
| 2020-02-13 5:16 pm Sale | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | Broadfin Capital LLC | 1,236,368 5.05% | -419,769 (-25.35%) | View |
| 2020-02-12 4:15 pm Purchase | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,225,000 9.08% | 450,000 (+25.35%) | View |
| 2020-02-07 08:45 am Purchase | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | BlackRock Inc. BLK | 1,889,692 7.7% | 1,889,692 (New Position) | View |
| 2019-11-18 5:27 pm Unchanged | 13D | EIGER BIOPHARMACEUTICALS INC C EIGR | Vivo Ventures VI LLC | 1,787,091 7.3% | 0 (Unchanged) | View |
| 2019-06-14 4:26 pm Purchase | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | Broadfin Capital LLC | 1,656,137 6.78% | 1,656,137 (New Position) | View |